We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UAMY icon
1226
United States Antimony
UAMY
$920M
$99K ﹤0.01%
245,500
– –
ZVIA icon
1227
Zevia
ZVIA
$106M
$98K ﹤0.01%
+35,000
New +$108K
SER icon
1228
Serina Therapeutics
SER
$35.2M
$98K ﹤0.01%
4,827
– –
RFL icon
1229
Rafael Holdings
RFL
$105M
$97K ﹤0.01%
52,379
+27,029
+107% +$53.9K
VERO
1230
DELISTED
Venus Concept
VERO
$97K ﹤0.01%
1,265
-1,212
-49% -$171K
SIEN
1231
DELISTED
Sientra, Inc.
SIEN
$95K ﹤0.01%
11,300
– –
AEY
1232
DELISTED
ADDvantage Technologies Group
AEY
$94K ﹤0.01%
7,500
– –
HYPD
1233
Hyperion DeFi Inc
HYPD
$40.5M
$93K ﹤0.01%
+599
New +$110K
FGNX
1234
FG Nexus Inc
FGNX
$40.2M
$93K ﹤0.01%
504
– –
CBIO
1235
Crescent Biopharma
CBIO
$610M
$93K ﹤0.01%
1,554
– –
AWX icon
1236
Avalon Holdings
AWX
$9.98M
$92K ﹤0.01%
35,500
– –
NRXP icon
1237
NRX Pharmaceuticals
NRXP
$132M
$92K ﹤0.01%
+15,370
New +$202K
SYRS
1238
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$91K ﹤0.01%
9,500
-7,500
-44% -$70.2K
SMMT icon
1239
Summit Therapeutics
SMMT
$10.8B
$89K ﹤0.01%
89,100
-40,000
-31% -$56.1K
VHC icon
1240
VirnetX Holding Corp
VHC
$67M
$89K ﹤0.01%
3,815
-4,550
-54% -$127K
AYLA
1241
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$89K ﹤0.01%
81,900
– –
BFX
1242
DELISTED
BowFlex Inc.
BFX
$88K ﹤0.01%
50,000
– –
APTX
1243
DELISTED
Aptinyx Inc. Common Stock
APTX
$88K ﹤0.01%
157,641
-49,659
-24% -$39.9K
ELTX icon
1244
Elicio Therapeutics
ELTX
$82.5M
$86K ﹤0.01%
7,500
-5,000
-40% -$79.9K
FTH
1245
Faeth Therapeutics
FTH
$631M
$86K ﹤0.01%
1,895
– –
SRGA
1246
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$86K ﹤0.01%
+25,156
New +$139K
BDSX icon
1247
Biodesix
BDSX
$229M
$82K ﹤0.01%
2,500
-1,750
-41% -$56.9K
MRKR icon
1248
Marker Therapeutics
MRKR
$18.7M
$82K ﹤0.01%
24,922
-7,500
-23% -$24.9K
WVVI icon
1249
Willamette Valley Vineyards
WVVI
$12M
$82K ﹤0.01%
13,000
– –
JVA icon
1250
Coffee Holding Co
JVA
$20M
$81K ﹤0.01%
33,000
– –
48 49
50
51 52

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.